582 related articles for article (PubMed ID: 25689352)
21. Prospective cohort of AIDS patients screened for cryptococcal antigenaemia, pre-emptively treated and followed in Brazil.
Borges MASB; de Araújo Filho JA; Oliveira BJS; Moreira IS; de Paula VV; de Bastos AL; Soares RBA; Turchi MD
PLoS One; 2019; 14(7):e0219928. PubMed ID: 31344140
[TBL] [Abstract][Full Text] [Related]
22. Prevalence, correlates, and outcomes of cryptococcal antigen positivity among patients with AIDS, United States, 1986-2012.
McKenney J; Bauman S; Neary B; Detels R; French A; Margolick J; Doherty B; Klausner JD
Clin Infect Dis; 2015 Mar; 60(6):959-65. PubMed ID: 25422390
[TBL] [Abstract][Full Text] [Related]
23. Cryptococcal-related Mortality Despite Fluconazole Preemptive Treatment in a Cryptococcal Antigen Screen-and-Treat Program.
Wake RM; Govender NP; Omar T; Nel C; Mazanderani AH; Karat AS; Ismail NA; Tiemessen CT; Jarvis JN; Harrison TS
Clin Infect Dis; 2020 Apr; 70(8):1683-1690. PubMed ID: 31179488
[TBL] [Abstract][Full Text] [Related]
24. Cost-effectiveness of serum cryptococcal antigen screening to prevent deaths among HIV-infected persons with a CD4+ cell count < or = 100 cells/microL who start HIV therapy in resource-limited settings.
Meya DB; Manabe YC; Castelnuovo B; Cook BA; Elbireer AM; Kambugu A; Kamya MR; Bohjanen PR; Boulware DR
Clin Infect Dis; 2010 Aug; 51(4):448-55. PubMed ID: 20597693
[TBL] [Abstract][Full Text] [Related]
25. Asymptomatic serum cryptococcal antigenemia and early mortality during antiretroviral therapy in rural Uganda.
Liechty CA; Solberg P; Were W; Ekwaru JP; Ransom RL; Weidle PJ; Downing R; Coutinho A; Mermin J
Trop Med Int Health; 2007 Aug; 12(8):929-35. PubMed ID: 17697087
[TBL] [Abstract][Full Text] [Related]
26. Establishing a cost-per-result of laboratory-based, reflex Cryptococcal antigenaemia screening (CrAg) in HIV+ patients with CD4 counts less than 100 cells/μl using a Lateral Flow Assay (LFA) at a typical busy CD4 laboratory in South Africa.
Cassim N; Schnippel K; Coetzee LM; Glencross DK
PLoS One; 2017; 12(2):e0171675. PubMed ID: 28166254
[TBL] [Abstract][Full Text] [Related]
27. Preventing deaths from cryptococcal meningitis: from bench to bedside.
Roy M; Chiller T
Expert Rev Anti Infect Ther; 2011 Sep; 9(9):715-7. PubMed ID: 21905781
[TBL] [Abstract][Full Text] [Related]
28. Prevalence of cryptococcal infection among advanced HIV patients in Argentina using lateral flow immunoassay.
Frola C; Guelfand L; Blugerman G; Szyld E; Kaufman S; Cahn P; Sued O; Pérez H
PLoS One; 2017; 12(6):e0178721. PubMed ID: 28617817
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of cryptococcal antigenemia and cost-effectiveness of a cryptococcal antigen screening program--Vietnam.
Smith RM; Nguyen TA; Ha HT; Thang PH; Thuy C; Lien TX; Bui HT; Le TH; Struminger B; McConnell MS; Fanfair RN; Park BJ; Harris JR
PLoS One; 2013; 8(4):e62213. PubMed ID: 23626792
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of cryptococcal antigenuria at initial HIV diagnosis in KwaZulu-Natal.
Drain PK; Kleene JM; Coleman SM; Losina E; Katz JN; Giddy J; Ross D; Freedberg KA; Bassett IV
HIV Med; 2015 Nov; 16(10):640-4. PubMed ID: 25958770
[TBL] [Abstract][Full Text] [Related]
31. Outcomes of Reflex Cryptococcal Antigen (CrAg) Screening in Human Immunodeficiency Virus (HIV)-Positive Patients With CD4 Counts of 100-200 Cells/µL in Botswana.
Tenforde MW; Milton T; Rulaganyang I; Muthoga C; Tawe L; Chiller T; Greene G; Jordan A; Williams CG; Owen L; Leeme TB; Boose A; Ngidi J; Mine M; Jarvis JN
Clin Infect Dis; 2021 May; 72(9):1635-1638. PubMed ID: 32604411
[TBL] [Abstract][Full Text] [Related]
32. High prevalence of cryptococcal infection among HIV-infected patients hospitalized with pneumonia in Thailand.
Harris JR; Lindsley MD; Henchaichon S; Poonwan N; Naorat S; Prapasiri P; Chantra S; Ruamcharoen F; Chang LS; Chittaganpitch M; Mehta N; Peruski L; Maloney SA; Park BJ; Baggett HC
Clin Infect Dis; 2012 Mar; 54(5):e43-50. PubMed ID: 22198791
[TBL] [Abstract][Full Text] [Related]
33. Six-month outcomes of HIV-infected patients given short-course fluconazole therapy for asymptomatic cryptococcal antigenemia.
Kapoor SW; Magambo KA; Kalluvya SE; Fitzgerald DW; Peck RN; Downs JA
AIDS; 2015 Nov; 29(18):2473-8. PubMed ID: 26372487
[TBL] [Abstract][Full Text] [Related]
34. Different presentations and outcomes between HIV-infected and HIV-uninfected patients with Cryptococcal meningitis.
Liao CH; Chi CY; Wang YJ; Tseng SW; Chou CH; Ho CM; Lin PC; Ho MW; Wang JH
J Microbiol Immunol Infect; 2012 Aug; 45(4):296-304. PubMed ID: 22608531
[TBL] [Abstract][Full Text] [Related]
35. Cost-effectiveness of CRAG-LFA screening for cryptococcal meningitis among people living with HIV in Uganda.
Ramachandran A; Manabe Y; Rajasingham R; Shah M
BMC Infect Dis; 2017 Mar; 17(1):225. PubMed ID: 28335769
[TBL] [Abstract][Full Text] [Related]
36. Cryptococcal Antigenemia in Human Immunodeficiency Virus Antiretroviral Therapy-Experienced Ugandans With Virologic Failure.
Mpoza E; Rajasingham R; Tugume L; Rhein J; Nabaggala MS; Ssewanyana I; Nyegenye W; Kushemererwa GE; Mulema V; Kalamya J; Kiyaga C; Kabanda J; Ssali M; Boulware DR; Meya DB
Clin Infect Dis; 2020 Oct; 71(7):1726-1731. PubMed ID: 31679007
[TBL] [Abstract][Full Text] [Related]
37. High prevalence of cryptococcal antigenaemia amongst asymptomatic advanced HIV patients in Pune, India.
Kadam D; Chandanwale A; Bharadwaj R; Nevrekar N; Joshi S; Patil S; Gupte N; Sangle S; Chopade K; Kulkarni V; Balasubramanian U; Suryavanshi N; Jain D; Kanade S; Dharmashale S; Kagal A; Gupta A; Mave V
Indian J Med Microbiol; 2017; 35(1):105-108. PubMed ID: 28303828
[TBL] [Abstract][Full Text] [Related]
38. Cryptococcal antigenemia in anti-retroviral naïve AIDS patients: prevalence and its association with CD4 cell count.
Osazuwa OF; Dirisu O; Okuonghae E
Acta Med Iran; 2012; 50(5):344-7. PubMed ID: 22837089
[TBL] [Abstract][Full Text] [Related]
39. Reflexive Laboratory-Based Cryptococcal Antigen Screening and Preemptive Fluconazole Therapy for Cryptococcal Antigenemia in HIV-Infected Individuals With CD4 <100 Cells/µL: A Stepped-Wedge, Cluster-Randomized Trial.
Meya DB; Kiragga AN; Nalintya E; Morawski BM; Rajasingham R; Park BJ; Mubiru A; Kaplan JE; Manabe YC; Boulware DR
J Acquir Immune Defic Syndr; 2019 Feb; 80(2):182-189. PubMed ID: 30399034
[TBL] [Abstract][Full Text] [Related]
40. CD4 Cell Count Threshold for Cryptococcal Antigen Screening of HIV-Infected Individuals: A Systematic Review and Meta-analysis.
Ford N; Shubber Z; Jarvis JN; Chiller T; Greene G; Migone C; Vitoria M; Doherty M; Meintjes G
Clin Infect Dis; 2018 Mar; 66(suppl_2):S152-S159. PubMed ID: 29514236
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]